![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07K 16/10 | (2006.01) |
A61P 31/14 | (2006.01) | ||
A61K 39/00 | (2006.01) |
(11) | Number of the document | 3889177 |
(13) | Kind of document | T |
(96) | European patent application number | 20186667.0 |
Date of filing the European patent application | 2020-07-20 | |
(97) | Date of publication of the European application | 2021-10-06 |
(45) | Date of publication and mention of the grant of the patent | 2023-01-11 |
(46) | Date of publication of the claims translation | 2023-02-10 |
(30) | Number | Date | Country code |
202063004312 P | 2020-04-02 | US | |
202063014687 P | 2020-04-23 | US | |
202063025949 P | 2020-05-15 | US | |
202063034865 P | 2020-06-04 | US | |
202016912678 | 2020-06-25 | US | |
PCT/US2020/039707 | 2020-06-25 | WO |
(72) |
BABB, Robert , US
BAUM, Alina , US
CHEN, Gang , US
GERSON, Cindy , US
HANSEN, Johanna , US
HUANG, Tammy , US
KYRATSOUS, Christos , US
LEE, Wen-Yi , US
MALBEC, Marine , US
MURPHY, Andrew , US
OLSON, William , US
STAHL, Neil , US
YANCOPOULOS, George D. , US
|
(73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Antikūnai prieš SARS-CoV-2 spyglio glikoproteiną ir antigeną surišiantys fragmentai |
ANTI-SARS-COV-2-SPIKE GLYCOPROTEIN ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS |
Payment date | Validity (years) | Amount | |
2025-06-19 | 6 | 139.00 EUR |
2026-07-20 |